Multimodal nanotechnology integrated with standardized nursing management offers a promising theranostic approach for ventricular arrhythmias, though significant translational barriers remain.
Multimodal nanotechnology presents a promising theranostic frontier for ventricular arrhythmias, but successful clinical translation will require overcoming unique cardiac physiological barriers and integrating these innovations with standardized nursing protocols.
Abstract Ventricular arrhythmias, particularly ventricular fibrillation, remain a leading cause of sudden cardiac death and pose persistent clinical challenges due to limitations in targeted therapy and the complexity of arrhythmogenic substrates. multimodal nanotechnology has emerged as a promising platform enabling integrated diagnostic and therapeutic functions; however, direct evidence for its application in cardiology remains limited compared to oncology, and significant translational barriers persist. Concurrently, comprehensive nursing and standardized management are critical for optimizing patient outcomes through continuous monitoring, timely intervention, and holistic care. This review critically synthesizes current evidence on multimodal nanotechnology applications in ventricular arrhythmia management, distinguishing between established cardiovascular findings and conceptual extrapolations from other fields. It analyzes technological advantages alongside cardiac-specific limitations—including myocardial targeting challenges, pro-arrhythmic risks, and regulatory complexity. Furthermore, it examines how nanotechnology-based therapies will impact nursing workflows, monitoring protocols, and competency requirements, proposing a framework for integrating these innovations with standardized nursing management. By bridging cutting-edge technological advances with clinical nursing strategies, this article provides a theoretical foundation and practical guidance for fostering multidisciplinary collaboration and advancing comprehensive, patient-centered treatment paradigms for ventricular arrhythmias.
Ding et al. (Fri,) conducted a review in Ventricular arrhythmia. Multimodal nanotechnology and standardized nursing management was evaluated. Multimodal nanotechnology integrated with standardized nursing management offers a promising theranostic approach for ventricular arrhythmias, though significant translational barriers remain.